Department of Pediatrics, The University of Nigeria Teaching Hospital Ituku-Ozalla Enugu, Enugu, Nigeria.
Department of Pediatrics, Enugu State University Teaching Hospital, Enugu, Nigeria.
BMC Infect Dis. 2023 Mar 14;23(1):159. doi: 10.1186/s12879-023-08077-3.
Some studies have reported the possible role of vitamin D in ameliorating disease outcomes in childhood infectious diarrhea. However, findings about its effectiveness and the association of serum vitamin D levels with diarrhea risk appear inconsistent. We aimed to determine the efficacy of oral vitamin D as an adjunct in managing childhood infectious diarrhea and the relationship between vitamin D status and the disease.
We searched the PubMed and Google Scholar electronic databases for relevant articles without limiting their year of publication. We selected primary studies that met the review's inclusion criteria, screened their titles and abstracts, and removed duplicates. We extracted data items from selected studies using a structured data-extraction form. We conducted a quality assessment of randomized controlled trials (RCTs) and non-randomized studies with the Cochrane collaboration tool and the Newcastle Ottawa Scale, respectively. We assessed the strength of the relationship between serum vitamin D levels and diarrhea using the correlation model. We estimated the I and tau values to assess between-study heterogeneity.
Nine full-text articles were selected, consisting of one RCT, three cross-sectional studies, two cohort studies, two longitudinal/prospective studies, and one case-control study. A total of 5,545 participants were evaluated in the nine studies. Six non-randomized studies provided weak evidence of the relationship between vitamin D levels and diarrhea risk as there was no correlation between the two variables. The only RCT failed to demonstrate any beneficial role of vitamin D in reducing the risk of recurrent diarrhea. The calculated I and tau values of 86.5% and 0.03, respectively suggested a high between-study heterogeneity which precluded a meta-analysis of study results.
Oral vitamin D may not be an effective adjunct in managing childhood infectious diarrhea. Additionally, the relationship between vitamin D status and infectious diarrhea appears weak. We recommend more adequately-powered RCTs to determine the effectiveness of vitamin D as an adjunct therapy in infectious diarrhea.
一些研究报告了维生素 D 可能在改善儿童感染性腹泻的疾病结局方面的作用。然而,关于其有效性以及血清维生素 D 水平与腹泻风险之间的关联的发现似乎不一致。我们旨在确定口服维生素 D 作为辅助治疗儿童感染性腹泻的疗效,以及维生素 D 状态与疾病的关系。
我们在 PubMed 和 Google Scholar 电子数据库中搜索了相关文章,没有限制其发表年份。我们选择了符合综述纳入标准的原始研究,筛选了它们的标题和摘要,并去除了重复项。我们使用结构化的数据提取表格从选定的研究中提取数据项。我们使用 Cochrane 协作工具和纽卡斯尔-渥太华量表分别对随机对照试验 (RCT) 和非随机研究进行质量评估。我们使用相关模型评估血清维生素 D 水平与腹泻之间的关系强度。我们估计了 I 和 tau 值以评估研究间的异质性。
共选择了 9 篇全文文章,包括 1 项 RCT、3 项横断面研究、2 项队列研究、2 项纵向/前瞻性研究和 1 项病例对照研究。在这 9 项研究中,共评估了 5545 名参与者。6 项非随机研究提供了维生素 D 水平与腹泻风险之间关系的弱证据,因为这两个变量之间没有相关性。唯一的 RCT 未能证明维生素 D 在降低复发性腹泻风险方面有任何有益作用。计算得出的 I 和 tau 值分别为 86.5%和 0.03,表明研究间存在高度异质性,因此无法对研究结果进行荟萃分析。
口服维生素 D 可能不是治疗儿童感染性腹泻的有效辅助手段。此外,维生素 D 状态与感染性腹泻之间的关系似乎较弱。我们建议进行更多充分-powered 的 RCT,以确定维生素 D 作为感染性腹泻辅助治疗的有效性。